A COVID-19 vaccine is administered in Toronto on Monday, Dec. 14, 2020. THE CANADIAN PRESS/Frank Gunn

A COVID-19 vaccine is administered in Toronto on Monday, Dec. 14, 2020. THE CANADIAN PRESS/Frank Gunn

Clinical trials start for Canadian COVID-19 vaccine candidate

Dubbed COVAC-2, the vaccine hopeful was developed by the Vaccine and Infectious Disease Organization

Clinical trials have begun for another Canadian-made COVID-19 vaccine candidate, with three people receiving an initial dose on Wednesday.

The Canadian Center for Vaccinology says the first of 108 healthy adult volunteers received injections in Halifax. The placebo-controlled study will administer two doses to each volunteer, 28 days apart.

“It’s a product of Canadian science, so it bodes well for the ability to make vaccines here. We all want to have vaccine manufacturing capacity in Canada,” said Dr. Joanne Langley, a vaccine researcher with the centre.

She said that the pace of testing is careful, as different age groups, from younger to older, receive varying doses in a process that will unfold over the next two months.

Dubbed COVAC-2, the vaccine hopeful was developed by the Vaccine and Infectious Disease Organization, or VIDO, at the University of Saskatchewan in Saskatoon.

It’s the first of two subunit vaccines by VIDO to enter clinical testing. Subunit vaccines contain purified viral proteins that are not infectious, and employ technology already used in vaccines for hepatitis, diphtheria, and whooping cough.

Darryl Falzarano, a vaccine researcher at VIDO, said he’s hoping that his institute’s promising tests on ferrets and hamsters will translate into safe and effective results in the human testing phase.

“Safety is the primary indicator (in the first phase) but you will also be looking at immune response,” he said.

Langley said the testing in the first phase is to determine safety to humans, and the participants will keep a diary that measure any pain or redness of the arm. The trial will also measure antibody responses, she said.

The next step would be to do trials at multiple sites around the country.

It is only in Phase 3 that the vaccine is compared against a placebo or another vaccine to see how well it protects against COVID-19, said Langley.

She said the entire vaccine testing process, if all went well, could take about nine months, adding that is a “very wishful, optimistic scenario.”

VIDO has said in a news release the product doesn’t need ultra-cold storage temperatures like synthetic messenger RNA or mRNA products. The two Health Canada-approved vaccines by Moderna and Pfizer-BioNTech each require special distribution and storage procedures that have complicated their rollout.

It follows the launch last month of clinical trials for a prospective vaccine by Calgary’s Providence Therapeutics, and last year’s launch of trials for a vaccine hopeful by Quebec City’s Medicago.

VIDO’s vaccine antigen – a molecule that triggers an immune response – was produced at Quebec-based Biodextris using a cell line from the National Research Council of Canada.

Development help also came from partners around the world, including Seppic in France and the Vaccine Formulation Institute in Switzerland.

At the same time, VIDO is building a manufacturing facility on the USask campus that could produce up to 40 million vaccine doses, but it wasn’t certain if that would include VIDO’s product. Construction is expected to be completed late this year.

Falzarano said the team in Saskatoon is excited the process is beginning, as this form of vaccine can be mass produced at a rapid rate if successful.

“It’s only the beginning of a multi-step process, but at least we’ve gotten to this milestone,” he said.

ALSO READ: Experts say race for COVID drugs dogged by false promises, lack of co-ordination

Michael Tutton and Cassandra Szklarski, The Canadian Press


Like us on Facebook and follow us on Twitter.

Want to support local journalism during the pandemic? Make a donation here.

Coronavirusvaccines

Just Posted

Jimmy Seymour was recognized for his outstanding work as the solid waste operator for Stz’uminus First Nation. (Submitted photo)
Top Jimmy: Ladysmith-area man takes your trash, leaves a smile

Jimmy Seymour uses his job as solid waste operator to spread kindness through Stz’uminus First Nation

Proprietor of Sweet Truck, Morgan Ray, as she hands off her baked goods to a customer. (Photo courtesy of Avrinder Dhillon Photography)
Vancouver Island baker eyes move back from food truck to bricks and mortar

Storefront offers more stability amid growth in sales: Ray

Emissions from the City of Abbotsford's vehicles make up the largest share of the municipality's emissions.
File photo
Vancouver Island councillor leads campaign to reduce building-sector GHG emissions

Courtenay’s Will Cole-Hamilton pushing for building emission legislation

Pictures and notes in from friends and classmates make up a memorial in support and memory of Aubrey Berry, 4, and her sister Chloe, 6, during a vigil held at Willows Beach in Oak Bay, B.C., on December 30, 2017. THE CANADIAN PRESS/Chad Hipolito
Mother of slain daughters supports recent changes to Canada’s Divorce Act

Sarah Cotton-Elliott said she believed her children took a back seat to arranging equal parenting

Thousands protested in Victoria following the death of George Floyd in the U.S. (Black Press Media file photo)
B.C. not exempt: New report documents 150 years of racism and the fight against it

Booklet marks province’s 150th anniversary with call for transparency, change

Elvira D’Angelo, 92, waits to receive her COVID-19 vaccination shot at a clinic in Montreal, Sunday, March 7, 2021, as the COVID-19 pandemic continues in Canada and around the world. THE CANADIAN PRESS/Graham Hughes
‘It’s been a good week’: Tam hopeful on vaccines as pandemic anniversary nears

Tam says the addition of two new vaccines will help Canadians get immunized faster

(The Canadian Press)
‘Worse than Sept. 11, SARS and financial crisis combined’: Tourism industry in crisis

Travel services saw the biggest drop in active businesses with 31 per cent fewer firms operating

A mobile home fire prompted a quick response from firefighters Saturday around 3:30 p.m. (Kevin Rothbauer/Citizen)
Mobile home up in flames at Duncan RV Park

One patient burned, EHS on scene

(Black Press Media files)
Medicine gardens help Victoria’s Indigenous kids in care stay culturally connected

Traditional plants brought to the homes of Indigenous kids amid the COVID-19 pandemic

Works crews have begun to install roads and other infrastructure to service the Nigel Valley redevelopment project that will bring nearly 800 new housing units to Saanich over the next several years. (Devon Bidal/News Staff)
Prep work begins on massive Nigel Valley development in Saanich

Construction of first two developments expected to begin fall 2021, B.C. Housing says

Gregory Ould, co-founder and executive director of Blanket BC, drops off warming blankets to Our Home on Eighth shelter in Port Alberni during a tour of Vancouver Island on Feb. 19, 2021. (SUSAN QUINN/ Alberni Valley News)
Blanket BC delivers warmth, hope to Vancouver Island’s homeless

Gregory Ould donated blankets, toques in five communities

Duncan Christian’s Grace George lines up a shot during the three-point portion of the BC School Sports Pandemic Basketball Challenge after taking a pass from Cam Stevens. (Kevin Rothbauer/Citizen)
Duncan Christian leads the way in pandemic basketball challenge

School tops participation numbers for second time this year

The shadow cast of the Satyr Players production of ‘The Rocky Horror Picture Show’: Linda Dohmeier as Dr. Scott, Olivia Erickson as Columbia, Brandon Caul as Rocky, Christopher Carter as Brad, Charlie Prince as Eddie, Branden Martell as Riff Raff, Jenna Morgan as Magenta, Megan Rhode as Janet and Adrien Kennedy as Dr. Frank-N-Furter (clockwise from left). (Josef Jacobson/The News Bulletin)
VIU student actors go online for 25th-annual ‘Rocky Horror Picture Show’

Satyr Players theatre company to broadcast pre-recorded shadow production

Most Read